SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com) today announced that an editorial advocating hyperthermia treatment was published in The Lancet Oncology, the premier worldwide journal for original oncology research. The editorial on the evolving role of hyperthermia in cancer therapy was titled “Hyperthermia in cancer: is it coming of age?” [The Lancet Oncol, Vol:15, Issue 6, pages 565-566, May 2014; doi: 10.1016/S1470-2045(14)70207-4.] The editorial was written by Professors Adam Januszewski and Justin Stebbing, Department of Surgery & Cancer, Imperial College London.
Help employers find you! Check out all the jobs and post your resume.
